Status | Study |
Active, not recruiting |
Study Name: Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2012-11-15 Interventions: Biological: bevacizumab Given |
Recruiting |
Study Name: Carboplatin in Treating Patients With Recurrent High-Grade Gliomas Condition: Adult Anaplastic Astrocytoma Adult Anaplastic Oligodendroglioma Date: 2012-07-17 Interventions: Drug: carboplatin Carboplatin |
Terminated |
Study Name: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2012-04-09 Interventions: Drug: aminolevulinic acid Give |
Completed |
Study Name: Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma Condition: Adult Glioblastoma Depression Recurrent Date: 2011-04-26 Interventions: Drug: vorinostat Given orally |
Terminated |
Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2010-05-11 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2009-09-18 Interventions: Drug: vismodegib Given orally |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme Condition: Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gli Date: 2008-03-21 Interventions: Drug: vorinostat Given orally |
Terminated |
Study Name: Risk Factors for Adult-Onset Brain Tumors Condition: Brain Neoplasm, Primary Brain Neoplasms, Malignant Brain N Date: 2008-01-07 |
Completed |
Study Name: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma Condition: Adult Glioblastoma Adult Gliosarcoma Recurrent Date: 2007-02-08 Interventions: Drug: irinotecan hydrochloride |
Terminated |
Study Name: Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Condition: Adult Brain Tumors Date: 2006-10-12 Interventions: Drug: erlotinib hydrochloride Tarceva will be self-administered in an open-label, unblinded manner to al |